Stockhub

Ipca Laboratories Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 19:0719:07, 21 September 2022‎ 95.149.241.133 talk‎ 1,064 bytes +1,064‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Ipca_Laboratories_Limited’